Our data suggest that concurrently with the coronavirus disease 2019 pandemic, a selection of fluconazole-resistant isolates has occurred in Spain, and the expansion of specific clones has been noted across centers. Further research is needed to determine the factors that underlie the successful expansion of these clones and their potential genetic relatedness.
